STAT1 and Alzheimer disease: In addition, at the protein level, verteporfin was effective in inhibiting YAP and TAZ expression and reducing levels of TSLP, STAT1, STAT2, STAT3, P-STAT3, JAK1 and JAK2, which are key signaling factors in AD.